Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation

被引:16
作者
Chiu, King-Wah [1 ]
Nakano, Toshiaki [1 ]
Hu, Tsung-Hui [1 ]
Tseng, Hui-Peng [1 ]
Cheng, Yu-Fan [1 ]
Jawan, Bruno [1 ]
Eng, Hock-Liew [1 ]
Goto, Shigeru [1 ]
Chen, Chao-Long [1 ]
机构
[1] Chang Gung Mem Hosp, Liver Transplant Program, Kaohsiung Med Ctr, Kaohsiung 833, Taiwan
关键词
CYP2C19; genotype; cytochrome P450; graft liver; homogenous; living donor liver transplantation; REFLUX ESOPHAGITIS; LANSOPRAZOLE; POLYMORPHISM; POPULATIONS; RECURRENCE; RECIPIENTS; ENZYMES; ALLELES;
D O I
10.1111/j.1365-2362.2011.02589.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The donor liver grafts with different allelic patterns do not affect CYP2C19 genotypes in the peripheral blood of living donor liver transplantation (LDLT) recipients. Aim This study investigated the influence of graft liver CYP2C19 genotypes on recipients who received the same or different CYP2C19 genotypes from donors after LDLT. Methods There were 30 donors and 30 recipients with the same CYP2C19 genotypes and 47 donors and 47 recipients with different CYP2C19 genotypes. Genomic DNA was isolated from the liver tissue of recipients. The CYP2C19 haplotypes were determined by polymerase chain reaction. Results A homogenous phenomenon in the sequences of graft liver CYP2C19 genotypes was indicated because the recipients showed mixed patterns that were similar to that of the original donor after LDLT. A significant decrease in homozygous extensive metabolizer (HomEM) and an increase in poor metabolizer (PM) distribution were observed in recipients with different CYP2C19 genotypes from their donors compared with recipients with the same CYP2C19 genotype as their donors (P < 0.05). Conclusions Homogenous phenomenon of sequence changes in graft liver CYP2C19 from the different genotypes between the donors and the recipients may play a role in graft stability by causing decreased HomEM and increased PM after LDLT.
引用
收藏
页码:352 / 356
页数:5
相关论文
共 12 条
[1]  
Chiu KW, 2010, ANN TRANSPL, V15, P38
[2]   Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation [J].
Chiu, King-Wah ;
Tai, Wei-Chen ;
Nakano, Toshiaki ;
Tseng, Hui-Peng ;
Cheng, Yu-Fan ;
Jawan, Bruno ;
Goto, Shigeru ;
Chen, Chao-Long .
CLINICAL TRANSPLANTATION, 2010, 24 (06) :830-834
[3]  
Chiu KW, 2005, HEPATO-GASTROENTEROL, V52, P1825
[4]  
Chiu KW, 2011, HEPATOGASTR IN PRESS
[5]   Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease [J].
Congiu, Mario ;
Mashford, Maurice L. ;
Slavin, John L. ;
Desmond, Paul V. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (06) :1038-1044
[6]   Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells [J].
Flagler, K. ;
Alexeev, V. ;
Pierce, E. A. ;
Igoucheva, O. .
GENE THERAPY, 2008, 15 (14) :1035-1048
[7]   Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations [J].
Goldstein, JA ;
Ishizaki, T ;
Chiba, K ;
deMorais, SMF ;
Bell, D ;
Krahn, PM ;
Evans, DAP .
PHARMACOGENETICS, 1997, 7 (01) :59-64
[8]   Impact of Intestinal CYP2C19 Genotypes on the Interaction between Tacrolimus and Omeprazole, but Not Lansoprazole, in Adult Living-Donor Liver Transplant Patients [J].
Hosohata, Keiko ;
Masuda, Satohiro ;
Katsura, Toshiya ;
Takada, Yasutsugu ;
Kaido, Toshimi ;
Ogura, Yasuhiro ;
Oike, Fumitaka ;
Egawa, Hiroto ;
Uemoto, Shinji ;
Inui, Ken-ichi .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (04) :821-826
[9]   Cytochrome P4502C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis [J].
Kawamura, Masashi ;
Ohara, Shuichi ;
Koike, Tomoyuki ;
Iijima, Katsunori ;
Suzuki, Hitoshi ;
Kayaba, Shoichi ;
Noguchi, Kenji ;
Abe, Shinya ;
Noguchi, Mitsunori ;
Shimosegawa, Toru .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (02) :222-226
[10]  
Saitoh T, 2009, HEPATO-GASTROENTEROL, V56, P703